0000899243-19-007996.txt : 20190315 0000899243-19-007996.hdr.sgml : 20190315 20190315175018 ACCESSION NUMBER: 0000899243-19-007996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170622 FILED AS OF DATE: 20190315 DATE AS OF CHANGE: 20190315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS NV CENTRAL INDEX KEY: 0000313216 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 19686197 BUSINESS ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC BUSINESS PHONE: 31 20 59 77777 MAIL ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC FORMER NAME: FORMER CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV DATE OF NAME CHANGE: 19981217 FORMER NAME: FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V DATE OF NAME CHANGE: 19930727 FORMER NAME: FORMER CONFORMED NAME: PHILIPS NV DATE OF NAME CHANGE: 19910903 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-22 0 0001528557 Corindus Vascular Robotics, Inc. CVRS 0000313216 KONINKLIJKE PHILIPS NV PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC AMSTERDAM P7 NETHERLANDS 1 0 1 0 Common Stock, par value $0.0001 per share 2017-12-15 4 A 0 9174 0.00 A 26368032 I See footnote Common Stock, par value $0.0001 per share 2018-05-31 4 A 0 53326 0.7501 A 26421358 I See footnote Non-qualified stock option (right to buy) 1.68 2017-06-22 4 A 0 17857 0.00 A 2027-06-21 Common Stock 17857 17857 I See footnote The common stock represents shares issuable upon vesting of restricted stock units ("RSUs") granted to Nathan Harrington in his capacity as a director of Corindus Vascular Robotics, Inc. (the "Issuer") as part of his 2017 annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The RSUs provide for vesting in quarterly installments on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with the Issuer. These securities are held directly by Nathan Harrington, an employee of the reporting person, as compensation for his service as a director of the Issuer. Pursuant to Mr. Harrington's arrangement with the reporting person as his employer, any compensation received by Mr. Harrington during his service as a director of the Issuer is for the benefit of the reporting person and, as such, Mr. Harrington intends to transfer his securities to the reporting person for no consideration. The common stock represents shares issuable upon vesting of RSUs granted to Mr. Harrington in his capacity as a director of the Issuer as part of his 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to Mr. Harrington's continuous service with the Issuer through each such vesting date. Includes 9,174 shares of common stock related to RSUs granted as part of Mr. Harrington's 2017 annual equity award which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with Issuer through each such vesting date The underlying shares vest over a period of three years with 33.33% vesting on the first anniversary of the issuance date and 8.334% vesting at the end of each calendar quarter thereafter. Mr. Harrington is an employee of the reporting person and serves as a director of the Issuer. As a result, the reporting person may be deemed a director by deputization for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. /s/ Abhijit Bhattacharya, Chief Financial Officer 2019-03-15 /s/ Marnix van Ginneken, Chief Legal Officer 2019-03-15